Driving Precision of Pediatric VTE Risk-stratification through Genetics.


Journal

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science
ISSN: 2153-4063
Titre abrégé: AMIA Jt Summits Transl Sci Proc
Pays: United States
ID NLM: 101539486

Informations de publication

Date de publication:
2024
Historique:
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

This study addresses rising incidence of pediatric venous thromboembolism by validating a VTE phenotype and developing a polygenic risk score (PRS) using UK Biobank data. Our findings demonstrate predictive value of the PRS, enhancing VTE risk assessment in clinical settings. Future steps involve integrating the PRS into risk stratification models.

Identifiants

pubmed: 38827080
pii: 2332
pmc: PMC11141856

Types de publication

Journal Article

Langues

eng

Pagination

498

Informations de copyright

©2024 AMIA - All rights reserved.

Auteurs

Samaya S Badrieh (SS)

University of Washington, Seattle, Washington.

Lisa Bastarache (L)

Vanderbilt University Medical Center, Nashville, Tennessee.

Xinnan Niu (X)

Vanderbilt University Medical Center, Nashville, Tennessee.

Jing He (J)

Vanderbilt University Medical Center, Nashville, Tennessee.

Jamie R Robinson (JR)

Vanderbilt University Medical Center, Nashville, Tennessee.

Classifications MeSH